Search Results - "Sprenkle, Preston C."

Generalizable Multi-Site Training and Testing Of Deep Neural Networks Using Image Normalization by Onofrey, John A., Casetti-Dinescu, Dana I., Lauritzen, Andreas D., Sarkar, Saradwata, Venkataraman, Rajesh, Fan, Richard E., Sonn, Geoffrey A., Sprenkle, Preston C., Staib, Lawrence H., Papademetris, Xenophon

“…The ability of medical image analysis deep learning algorithms to generalize across multiple sites is critical for clinical adoption of these methods. Medical…”
Get full text

Association between pelvic lymph node dissection and survival among patients with prostate cancer treated with radical prostatectomy by Kim, Isaac E., Wang, Aaron H., Corpuz, George S., Sprenkle, Preston C., Leapman, Michael S., Brito, Joseph M., Renzulli, Joseph, Kim, Isaac Yi

“…Although the clinical benefits of pelvic lymph node dissection (PLND) at the time of radical prostatectomy for prostate cancer remain uncertain, major…”
Get full text

Diagnostic utility of prostate health index density prior to MRI-ultrasound fusion targeted biopsy by Press, Benjamin H, Lokeshwar, Soum D, Webb, Lindsey, Khajir, Ghazal, Smani, Shayan, Olawoyin, Olamide, Gardezi, Mursal, Rahman, Syed N, Leapman, Michael S, Sprenkle, Preston C

“…Prostate biopsy can be prone to complications and thus should be avoided when unnecessary. Although the combination of magnetic resonance imaging (MRI), the…”
Get full text

Association Between a 22-feature Genomic Classifier and Biopsy Gleason Upgrade During Active Surveillance for Prostate Cancer by Press, Benjamin H., Jones, Tashzna, Olawoyin, Olamide, Lokeshwar, Soum D., Rahman, Syed N., Khajir, Ghazal, Lin, Daniel W., Cooperberg, Matthew R., Loeb, Stacy, Darst, Burcu F., Zheng, Yingye, Chen, Ronald C., Witte, John S., Seibert, Tyler M., Catalona, William J., Leapman, Michael S., Sprenkle, Preston C.

“…The results from this study indicate that among patients with prostate cancer undergoing active surveillance, those with higher Decipher scores were more…”
Get full text

Prostate-Specific Antigen Trends Predict the Probability of Prostate Cancer in a Very Large U.S. Veterans Affairs Cohort by Karnes, R Jeffrey, MacKintosh, F Roy, Morrell, Christopher H, Rawson, Lori, Sprenkle, Preston C, Kattan, Michael W, Colicchia, Michele, Neville, Thomas B

“…If prostate-specific antigen (PSA) trends help identify elevated prostate cancer (PCa) risk, they might provide early warning of progressing cancer for further…”
Get full text

Prostate zonal anatomy correlates with the detection of prostate cancer on multiparametric magnetic resonance imaging/ultrasound fusion–targeted biopsy in patients with a solitary PI-RADS v2–scored lesion by Syed, Jamil S., B.S, Nguyen, Kevin A., M.S, Nawaf, Cayce B., M.D, Bhagat, Ansh M, Huber, Steffen, M.D, Levi, Angelique, M.D, Humphrey, Peter, M.D., Ph.D, Weinreb, Jeffrey C., M.D, Schulam, Peter G., M.D., Ph.D, Sprenkle, Preston C., M.D

“…Abstract Purpose To evaluate the positive predictive value (PPV) of the Prostate Imaging Reporting and Data System version 2 (PI-RADS v2) assessment method in…”
Get full text

Age and Prostate-Specific Antigen Level Prior to Diagnosis Predict Risk of Death from Prostate Cancer by MacKintosh, F Roy, Sprenkle, Preston C, Walter, Louise C, Rawson, Lori, Karnes, R Jeffrey, Morrell, Christopher H, Kattan, Michael W, Nawaf, Cayce B, Neville, Thomas B

“…A single early prostate-specific antigen (PSA) level has been correlated with a higher likelihood of prostate cancer diagnosis and death in younger men. PSA…”
Get full text

Doubling of Decipher Biopsy Genomic Score Is Related to Disease Reclassification on Subsequent Surveillance Biopsy but Not Adverse Features on Radical Prostatectomy by Ghabili, Kamyar, Paulson, Nathan, Syed, Jamil S., Nawaf, Cayce B., Khajir, Ghazal, Martin, Darryl T., Onofrey, John, Leapman, Michael S., Levi, Angelique, Weinreb, Jeffrey C., Humphrey, Peter A., Sprenkle, Preston C.

“…The utility of serial Decipher biopsy scores in a true active surveillance population is still unknown. In a man on active surveillance for low-risk prostate…”
Get full text

Role of Core Number and Location in Targeted Magnetic Resonance Imaging-Ultrasound Fusion Prostate Biopsy by Lu, Amanda Jane, Syed, Jamil S., Ghabili, Kamyar, Hsiang, Walter Robert, Nguyen, Kevin A., Leapman, Michael S., Sprenkle, Preston C.

“…The optimal method of magnetic resonance imaging (MRI)-ultrasound (US) fusion biopsy to adequately sample regions of interest (ROIs) remains unknown. We sought…”
Get full text

Reliable Prostate Cancer Risk Mapping from MRI Using Targeted and Systematic Core Needle Biopsy Histopathology by Zeevi, Tal, Leapman, Michael S., Sprenkle, Preston C., Venkataraman, Rajesh, Staib, Lawrence H., Onofrey, John A.

“…Objective: To compute a dense prostate cancer risk map for the individual patient post-biopsy from magnetic resonance imaging (MRI) and to provide a more…”
Get full text

Risk of Clinically Significant Prostate Cancer Associated With Prostate Imaging Reporting and Data System Category 3 (Equivocal) Lesions Identified on Multiparametric Prostate MRI by Sheridan, Alison D, Nath, Sameer K, Syed, Jamil S, Aneja, Sanjay, Sprenkle, Preston C, Weinreb, Jeffrey C, Spektor, Michael

“…The objective of this study is to determine the frequency of clinically significant cancer (CSC) in Prostate Imaging Reporting and Data System (PI-RADS)…”
Get full text

The Prognostic Association of Prostate MRI PI-RADS™ v2 Assessment Category and Risk of Biochemical Recurrence after Definitive Local Therapy for Prostate Cancer: A Systematic Review and Meta-Analysis by Rajwa, Pawel, Mori, Keiichiro, Huebner, Nicolai A, Martin, Darryl T, Sprenkle, Preston C, Weinreb, Jeffrey C, Ploussard, Guillaume, Pradere, Benjamin, Shariat, Shahrokh F, Leapman, Michael S

“…Although the Prostate Imaging-Reporting and Data System™ version 2 (PI-RADS™ v2) is a reliable diagnostic tool for significant prostate cancer, less is known…”
Get full text

Association of Crowd-Sourced Assessment of Technical Skills and Outcomes of Robotic-assisted Radical Prostatectomy by Rabil, Maximilian J., Jalfon, Michael, Heckscher, Dylan, Song, Zhiqian, Li, Fangyong, Martin, Thomas, Sprenkle, Preston C., Hesse, David, Kim, Isaac Y., Leapman, Michael S., Cavallo, Jaime A.

“…To investigate if use of the Crowd-Sourced Assessment of Technical Skills (CSATS) platform and video peer review with constructive feedback is associated with…”
Get full text

Multi‐institutional analysis of clinical and imaging risk factors for detecting clinically significant prostate cancer in men with PI‐RADS 3 lesions by Fang, Andrew M., Shumaker, Luke A., Martin, Kimberly D., Jackson, Jamaal C., Fan, Richard E., Khajir, Ghazal, Patel, Hiten D., Soodana‐Prakash, Nachiketh, Vourganti, Srinivas, Filson, Christopher P., Sonn, Geoffrey A., Sprenkle, Preston C., Gupta, Gopal N., Punnen, Sanoj, Rais‐Bahrami, Soroush

“…Background Most Prostate Imaging–Reporting and Data System (PI‐RADS) 3 lesions do not contain clinically significant prostate cancer (CSPCa; grade group ≥2)…”
Get full text

Changes in Prostate-Specific Antigen Testing Relative to the Revised US Preventive Services Task Force Recommendation on Prostate Cancer Screening by Leapman, Michael S, Wang, Rong, Park, Henry, Yu, James B, Sprenkle, Preston C, Cooperberg, Matthew R, Gross, Cary P, Ma, Xiaomei

“…In April 2017, the US Preventive Services Task Force (USPSTF) published a draft guideline that reversed its 2012 guidance advising against prostate-specific…”
Get more information

Pathologic prostate cancer grade concordance among high-resolution micro-ultrasound, systematic transrectal ultrasound and MRI fusion biopsy by Lokeshwar, Soum D., Choksi, Ankur U., Smani, Shayan, Kong, Victoria, Sundaresan, Vinaik, Sutherland, Ryan, Brito, Joseph, Renzulli, Joseph F, Sprenkle, Preston C., Leapman, Michael S.

“…•For image guided prostate bipsy, MRI-microUS and MRI-TRUS fusion biopsy techniques were associated with similar rates of GG upgrade on final pathology after…”
Get full text

Cytologic evaluation of upper urinary tract specimens: An institutional retrospective study using The Paris System for Reporting Urine Cytology second edition with histopathologic follow‐up by Khajir, Ghazal, Sun, Tong, Wang, He, Sprenkle, Preston C., Adeniran, Adebowale J., Cai, Guoping, Levi, Angelique W.

“…Objective Cytologic evaluation of the upper urinary tract (UUT) can be challenging due to instrumentation artefacts. This study retrospectively reviewed UUT…”
Get full text

Comparison of Open and Minimally Invasive Partial Nephrectomy for Renal Tumors 4–7 Centimeters by Sprenkle, Preston C, Power, Nicholas, Ghoneim, Tarek, Touijer, Karim A, Dalbagni, Guido, Russo, Paul, Coleman, Jonathan A

“…Abstract Background Indications for partial nephrectomy (PN) in the treatment of renal cell carcinoma are evolving, particularly for larger, more complex…”
Get full text

Prostate-specific antigen screening for prostate cancer: Diagnostic performance, clinical thresholds, and strategies for refinement by Sundaresan, Vinaik M., Smani, Shayan, Rajwa, Pawel, Renzulli, Joseph, Sprenkle, Preston C., Kim, Isaac Y., Leapman, Michael S.

“…Prostate specific antigen (PSA) has transformed the diagnosis and treatment of prostate cancer by enabling early detection at global scale. Due to expression…”
Get full text

When and How Should Active Surveillance for Prostate Cancer be De-Escalated? by Rajwa, Pawel, Sprenkle, Preston C., Leapman, Michael S.

“…Despite widespread adoption of active surveillance (AS) for low-risk prostate cancer, less is known about how or when monitoring should be deintensified. We…”
Get full text